By mimicking the action of the GLP-1 hormone, semaglutide helps to: Decrease Appetite: Semaglutide signals the brain to reduce hunger pangs, making it easier for individuals to control their caloric intake
Generally, FDA-approved GLP-1 medications for chronic weight management are indicated for adults with a body mass index of 30 or higher, or adults with a BMI of 27 or higher who also have at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia
Prescriptions for weight management in Ozempic, Wegovy, Rybelsus, and Mounjaro increased by 2,082% from 2019 to 2022
cite Why prices vary so much Brand premiums, patents, and the manufacturer list price drive the high retail costs of Wegovy and Zepbound
[DOI] [PMC free article] [PubMed] [Google Scholar] 532